Abstracts tagged "ACR and C-reactive protein (CRP)"

Abstract Number: 1488 • 2019 ACR/ARP Annual Meeting
Ixekizumab Demonstrates Improvement Comparable to Adalimumab Across ACR Components in Biologic-Naïve Patients with Psoriatic Arthritis
M. Elaine Husni¹, Kristin Gowin ², Amanda Gellett ³, Aubrey Trevelin Sprabery ³, Cameron Helt ³, Vladimir Geneus ³ and Maurizio Rossini ⁴, ¹Department of Rheumatologic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, ²Asheville Arthritis & Osteoporosis Center, Asheville, NC, ³Eli Lilly and Company, Indianapolis, IN, ⁴University of Verona, Verona, Italy
Background/Purpose: In patients (pts) with active psoriatic arthritis (PsA) and inadequate response or intolerance to conventional synthetic DMARD (csDMARD), use of a biologic DMARD (bDMARD)…